You just read:

Flowonix® Medical Inc. And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy

News provided by

Flowonix Medical Inc.

14 Mar, 2017, 16:33 ET